Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinoma

被引：0
|
作者：
Yoshinami, Y. [1 ]
Yamamoto, S. [1 ]
Shiraishi, K. [1 ]
Itoyama, M. [1 ]
Imazeki, H. [1 ]
Yokoyama, K. [1 ]
Honma, Y. [1 ]
Kurita, D. [2 ]
Ishiyama, K. [2 ]
Oguma, J. [2 ]
Daiko, H. [2 ]
Kato, K. [1 ]
机构：
[1] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
415P
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
    Yoshinami, Yuri
    Yamamoto, Shun
    Kadono, Toru
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 373 - 373
  • [2] Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
    Wu, Zhigang
    Zheng, Qiang
    Chen, Haiquan
    Xiang, Jiaqing
    Hu, Hong
    Li, Hang
    Pan, Yunjian
    Peng, Yizhou
    Yao, Xingxin
    Liu, Pengcheng
    Sun, Yihua
    Li, Bin
    Zhang, Yawei
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (06) : 3518 - 3528
  • [3] Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma
    Leng, Xue-Feng
    Daiko, Hiroyuki
    Han, Yong-Tao
    Mao, You-Sheng
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 213 - 224
  • [4] Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin
    Toru Kadono
    Shun Yamamoto
    Toshiharu Hirose
    Go Ikeda
    Akihiro Ohara
    Mai Itoyama
    Kazuki Yokoyama
    Yoshitaka Honma
    Taiki Hashimoto
    Shigeki Sekine
    Koshiro Ishiyama
    Junya Oguma
    Hiroyuki Daiko
    Ken Kato
    [J]. Esophagus, 2023, 20 : 109 - 115
  • [5] Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin
    Kadono, Toru
    Yamamoto, Shun
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Hashimoto, Taiki
    Sekine, Shigeki
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    [J]. ESOPHAGUS, 2023, 20 (01) : 109 - 115
  • [6] Safety and short-term efficacy of preoperative FOLFOX therapy for patients with resectable esophageal squamous cell carcinoma who are not candidates for cisplatin
    Kadono, T.
    Yamamoto, S.
    Ohara, A.
    Itouyama, M.
    Yokoyama, K.
    Honma, Y.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Kato, K.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S250 - S250
  • [7] Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.
    Okunaka, Mashiro
    Kotani, Daisuke
    Sato, Kazuma
    Fujiwara, Naoto
    Mishima, Saori
    Shitara, Kohei
    Fujita, Takeo
    Kojima, Takashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 271 - 271
  • [8] Neoadjuvant chemoimmunotherapy was associated with better short-term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
    Duan, Xiaofeng
    Zhao, Fangdong
    Shang, Xiaobin
    Yue, Jie
    Chen, Chuangui
    Ma, Zhao
    Chen, Zuoyu
    Zhang, Chen
    Pang, Qingsong
    Zhang, Wencheng
    Abbas, Abbas E.
    Jiang, Hongjing
    [J]. CANCER MEDICINE, 2024, 13 (15):
  • [9] The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
    He, Wenwu
    Wang, Chenghao
    Li, Changding
    Nie, Xin
    Li, Haojun
    Li, Jialong
    Zhao, Na
    Chen, Haijun
    Miao, Xiaojie
    Han, Yongtao
    Peng, Lin
    Leng, Xuefeng
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
    He, Wenwu
    Leng, Xuefeng
    Mao, Tianqin
    Luo, Xi
    Zhou, Lingxiao
    Yan, Jiaxin
    Peng, Lin
    Fang, Qiang
    Liu, Guangyuan
    Wei, Xing
    Wang, Kangning
    Wang, Chenghao
    Zhang, Sha
    Zhang, Xudong
    Shen, Xudong
    Huang, Depei
    Yi, Huan
    Bei, Ting
    She, Xueke
    Xiao, Wenguang
    Han, Yongtao
    [J]. ONCOLOGIST, 2022, 27 (01): : E18 - E28
12345